188 related articles for article (PubMed ID: 27097221)
1. Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.
Kim DH; Choi BH; Ku SK; Park JH; Oh E; Kwak MK
PLoS One; 2016; 11(4):e0153965. PubMed ID: 27097221
[TBL] [Abstract][Full Text] [Related]
2. Combinational Use of Antiplatelet Medication Sarpogrelate with Therapeutic Drug Rosuvastatin in Treating High-Cholesterol Diet-Induced Chronic Kidney Disease in ApoE-Deficient Mice.
Xu J; Pei Z; Yu M; Li X; Wang L; Lin Y; Chen X; Liu X
Biomed Res Int; 2020; 2020():1809326. PubMed ID: 33029491
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin.
Park JH; Choi BH; Ku SK; Kim DH; Jung KA; Oh E; Kwak MK
Arch Pharm Res; 2017 Mar; 40(3):391-402. PubMed ID: 28084586
[TBL] [Abstract][Full Text] [Related]
4. A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1.
Hamasaki Y; Doi K; Maeda-Mamiya R; Ogasawara E; Katagiri D; Tanaka T; Yamamoto T; Sugaya T; Nangaku M; Noiri E
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1796-803. PubMed ID: 24107419
[TBL] [Abstract][Full Text] [Related]
5. Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice.
Chou YJ; Kan WC; Chang CM; Peng YJ; Wang HY; Yu WC; Cheng YH; Jhang YR; Liu HW; Chuu JJ
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649140
[TBL] [Abstract][Full Text] [Related]
6. Negative correlation of urinary miR-199a-3p level with ameliorating effects of sarpogrelate and cilostazol in hypertensive diabetic nephropathy.
Kim SK; Kim G; Choi BH; Ryu D; Ku SK; Kwak MK
Biochem Pharmacol; 2021 Feb; 184():114391. PubMed ID: 33359069
[TBL] [Abstract][Full Text] [Related]
7. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
[TBL] [Abstract][Full Text] [Related]
8. Effect of sarpogrelate on altered STZ-diabetes induced cardiovascular responses to 5-hydroxytryptamine in rats.
Umrani DN; Bodiwala DN; Goyal RK
Mol Cell Biochem; 2003 Jul; 249(1-2):53-7. PubMed ID: 12956398
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
12. Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice.
Tsai HC; Chang FP; Li TH; Liu CW; Huang CC; Huang SF; Yang YY; Lee KC; Hsieh YC; Wang YW; Lee TY; Huang YH; Hou MC; Lin HC
Biomed Res Int; 2019; 2019():6740616. PubMed ID: 31321239
[TBL] [Abstract][Full Text] [Related]
13. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
[TBL] [Abstract][Full Text] [Related]
14. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
Blaes N; Pécher C; Mehrenberger M; Cellier E; Praddaude F; Chevalier J; Tack I; Couture R; Girolami JP
Am J Physiol Renal Physiol; 2012 Jul; 303(2):F293-303. PubMed ID: 22573379
[TBL] [Abstract][Full Text] [Related]
17. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
Kang YS; Ko GJ; Lee MH; Song HK; Han SY; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2009 Jan; 24(1):73-84. PubMed ID: 18682491
[TBL] [Abstract][Full Text] [Related]
18. Sarpogrelate and rosuvastatin synergistically ameliorate aortic damage induced by hyperlipidemia in apolipoprotein E-deficient mice.
Liu H; Xu S; Li G; Lou D; Fu X; Lu Q; Hao L; Zhang J; Mei J; Sui Z; Lou Y
Exp Ther Med; 2020 Dec; 20(6):170. PubMed ID: 33093907
[TBL] [Abstract][Full Text] [Related]
19. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
Nicholas SB; Aguiniga E; Ren Y; Kim J; Wong J; Govindarajan N; Noda M; Wang W; Kawano Y; Collins A; Hsueh WA
Kidney Int; 2005 Apr; 67(4):1297-307. PubMed ID: 15780082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]